Operating Lease, Right-of-Use Asset in USD of Spyre Therapeutics, Inc. from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Spyre Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q4 2023.
  • Spyre Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Spyre Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$3.43M -100% 31 Dec 2023 10-K/A 18 Nov 2024
Q3 2023 $0 -$3.51M -100% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $2.32M -$1.3M -35.9% 30 Jun 2023 10-Q 11 Aug 2023
Q1 2023 $3.27M -$446K -12% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $3.43M -$376K -9.88% 31 Dec 2022 10-K/A 18 Nov 2024
Q3 2022 $3.51M -$383K -9.83% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $3.62M -$397K -9.9% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $3.71M -$411K -9.97% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $3.81M -$424K -10% 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 $3.9M -$497K -11.3% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $4.01M -$545K -12% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $4.12M -$589K -12.5% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $4.23M -$496K -10.5% 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 $4.39M -$478K -9.81% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $4.56M -$461K -9.19% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $4.71M +$4.09M +659% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $4.73M 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 $4.87M 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $5.02M 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 $621K 31 Mar 2019 10-Q 07 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.